| 2901 |
ZATHRIN 500 |
AZITHROMYCIN USP 500 MG |
FILM COATED TABLET |
ALU-PVC/PVDC BLISTER |
FOR THE FOLLOWING BACTERIAL INFECTIONSWHEN CAUSED BY MICROORGANISM SENSITIVE TO AZITHROMYCIN: ACUTE BACTERIAL SINUSITIS (ADEQUATELY DIAGNOSED), ACUTE BACTERIAL OTITIS MEDIA (ADEQUATELY DIAGNOSED), PHARYNGITIS AND TONSILLITIS, ACUTE EXACERBATION OF CHRONIC BRONCHITIS, MILD TO MODERATELY SEVERE COMMUNITY ACQUIRED PNEUMONIA, INFECTION OF THE SKIN AND SOFT TISSUE, UNCOMPLICATED CHLAMYDIA TRACHOMATIS URETHRITIS AND CERVICITIS |
NULL |
VIMPEX (LAO) CO.,LTD |
FDC LIMITED |
INDIA |
CERTIFICATE RELEASED |
08 I 5605/23 |
05-SEP-2023 |
04-SEP-2026 |
View |
| 2902 |
ZEPOSE 150 MG |
IRBESARTAN 150 MG |
TABLET |
ALU-ALU BLISTERPACK |
TREATMENT OF HYPERTENSION, OF DIABETIC NEPHROPATHY WITH AN ELEVATED SERUM CREATININE AND PROTEINURIA IN PATIENT WITH TYPE 2 DIABETES AND HYPERTENSION |
NULL |
VIMPEX (LAO) CO.,LTD |
WILSHIRE LABORATORIES(PVT) LTD |
PAKISTAN |
CERTIFICATE RELEASED |
11 I 4627/18 |
26-SEP-2022 |
25-SEP-2025 |
View |
| 2903 |
ZIFI-200 |
CEFIXIME TRIHYDRATE EQ.TO ANHYDROUS CEFIXIME 200 MG |
TABLET |
BLISTERPACK |
TREATMENT OF RESPIRATORY TRACT INFECTIONS, ACUTE OTITIS MEDIA, URINARY TRACT INFECTION, GONOCCOCAL URETHRITIS, TYPHOID AND SEQUENTIAL TREATMENT AFTER INITIAL I.V CHEMOTHERAPY BY PARENTERA CEPHALOSPORIN FOR SEVERE INFECTION |
NULL |
VIMPEX (LAO) CO.,LTD |
FDC LIMITED |
INDIA |
CERTIFICATE RELEASED |
08 I 5604/23 |
05-SEP-2023 |
04-SEP-2026 |
View |
| 2904 |
ZITHROX 250 |
AZITHROMYCIN DIHYDRATE BP 265.957 MG EQ.TO AZITHROMYCIN 250 MG |
FILM-COATED TABLETS |
ALU-ALU STRIPS |
INFECTIONS OF THE LOWER RESPIRATORY TRACT INCLUDING BRONCHITIS AND PNEUMONIA, INFECTIONS OF THE UPPER RESPIRATORY TRACT INCLUDING SINUSITIS, PHARYNGITIS AND TONSILITIS. OTITIS MEDIA, INFECTION OF SKIN AND SOFT TISSUE OF MILD TO MODERATE SEVERITY |
NULL |
VIMPEX (LAO) CO.,LTD |
ESKAYEF PHARMACEUTICALS LIMITED |
BANGLADESH |
CERTIFICATE RELEASED |
10 I 4614/18 |
07-JUL-2025 |
06-JUL-2030 |
View |
| 2905 |
ZITHROX 500 |
AZITHROMYCIN DIHYDRATE BP 524.045 MG EQ.TO AZITHROMYCIN 500 MG |
FILM-COATED TABLETS |
ALU-ALU STRIPS |
INFECTIONS OF THE LOWER RESPIRATORY TRACT INCLUDING BRONCHITIS AND PNEUMONIA, INFECTIONS OF THE UPPER RESPIRATORY TRACT INCLUDING SINUSITIS, PHARYNGITIS AND TONSILITIS. OTITIS MEDIA, INFECTION OF SKIN AND SOFT TISSUE OF MILD TO MODERATE SEVERITY |
NULL |
VIMPEX (LAO) CO.,LTD |
ESKAYEF PHARMACEUTICALS LIMITED |
BANGLADESH |
CERTIFICATE RELEASED |
10 I 4615/18 |
07-JUL-2025 |
06-JUL-2030 |
View |
| 2906 |
ZOCON 150 |
FLUCONAZOLE 150 MG |
TABLET |
BLISTERPACK |
IN THE TREATMENT OF SYSTEMIC CANDIDIASIS MUCOSAL CANDIDIASIS AND CRYPTOCOCCOSIS, TREATMENT OF VAGINAL CANDIDIASIS, PREVENTION OF FUNGAL INFECTIONS IN PATIENTS WITH MALIGNANCY |
NULL |
VIMPEX (LAO) CO.,LTD |
FDC LIMITED |
INDIA |
CERTIFICATE RELEASED |
06 I 5776/24 |
27-Jun-2024 |
26-Jun-2027 |
View |
| 2907 |
ZOCON EYE DROPS |
FLUCONAZOLE 0.3% W/V |
OPHTHALMIC SOLUTION |
VIAL |
TREATMENT OF FUNGAL CORNEAL ULCERS AND FUNGAL KERATITIS |
NULL |
VIMPEX (LAO) CO.,LTD |
FDC LIMITED |
INDIA |
CERTIFICATE RELEASED |
06 I 5777/24 |
27-Jun-2024 |
26-Jun-2027 |
View |
| 2908 |
ZOLERIC 20 MG |
ESOMEPRAZOLE MAGNESIUM TRIHYDRATE 22.3 MG EQ.TO ESOMEPRAZOLE PELLETS 20 MG |
CAPSULE |
ALU-ALU |
GASTROESOPHAGEAL REFLUX DISEASE, TREATMENT OF EROSIVE REFLUX ESOPHAGITIS, TREATMENT OF DUODENAL ULCERS CAUSED BY H.PYLORI, PREVENTION OF RELAPSE OF PEPTIC ULCERS IN PATIENTS WITH HELICOBACTER PYLORI ASSOCIATED ULCERS. |
NULL |
VIMPEX (LAO) CO.,LTD |
GENIX PHARMA(PRIVATE) LTD. |
PAKISTAN |
CERTIFICATE RELEASED |
03 I 4368/18 |
28-Mar-2025 |
27-Mar-2030 |
View |
| 2909 |
ZOLERIC 40 MG |
ESOMEPRAZOLE MAGNESIUM TRIHYDRATE 44.5 MG EQ.TO ESOMEPRAZOLE PELLETS 40 MG |
CAPSULE |
ALU-ALU |
GASTROESOPHAGEAL REFLUX DISEASE, TREATMENT OF EROSIVE REFLUX ESOPHAGITIS, TREATMENT OF DUODENAL ULCERS CAUSED BY H.PYLORI, PREVENTION OF RELAPSE OF PEPTIC ULCERS IN PATIENTS WITH HELICOBACTER PYLORI ASSOCIATED ULCERS. |
NULL |
VIMPEX (LAO) CO.,LTD |
GENIX PHARMA(PRIVATE) LTD. |
PAKISTAN |
CERTIFICATE RELEASED |
03 I 4371/18 |
28-Mar-2025 |
27-Mar-2030 |
View |
| 2910 |
ZOXAN EYE/EAR DROPS |
CIPROFLOXACIN HYDROCHLORIDE USP 0.3%W/V |
OPHTHALMIC SOLUTION |
VIAL |
EYE: TREATMENT OF CONJUNCTIVITIS, BLEPHARITIS, BACTERIALCORNEAL ULCER, BACTERIAL KERATITIS, KERATOCONJUNCTIVITIS, MEIBOMIANTIS CAUSED BY SUSCEPTIBLE BACTERIA, AS A PREOPERATIVE PROPHYLAXIS IN OCULAR SURGERY AND TREATMENT OF POST OPERATIVE OCULAR INFECTION. EAR: TREATMENT OF OTITIS EXTERNA, ACUTE OTITIS MEDIA, CHRONIC SUPPURATIVE OTITIS MEDIA AND AS A PROPHYLAXIS DURING OTIC SURGERIES SUCH AS MASTOID SURGERY |
NULL |
VIMPEX (LAO) CO.,LTD |
FDC LIMITED |
INDIA |
CERTIFICATE RELEASED |
06 I 5778/24 |
27-Jun-2024 |
26-Jun-2027 |
View |
